CPDN Canadian

Canadian Pharmaceutical Distribution Network (CPDN) is dedicated to ensuring that hospitals across Canada have access to essential medicines, particularly during challenging times such as the COVID-19 pandemic. Collaborating with 38 pharmaceutical manufacturers, CPDN prioritizes the continuity of supply and actively monitors inventory levels to meet the increasing demand for critical medications. In addition to maintaining a robust supply chain, CPDN employs tools like the online Allocation Tool to facilitate equitable product distribution and prevent stockpiling. The organization emphasizes the importance of communication and support for healthcare professionals, reinforcing its commitment to patient care and safety during unprecedented challenges. Generated from the website

Mountain Valley MD Holdings Inc. (MVMD) is a biotech company based in Oakville, Ontario, dedicated to advancing solutions that optimize human, animal, and plant health. With a focus on sustainable agricultural solutions, nutraceuticals, and animal husbandry, MVMD is committed to creating innovative technologies that enhance overall well-being. The company is currently entering a pivotal commercialization phase, backed by successful global trials and strong market demand for its flagship product, Agrarius. MVMD's transformative progress across its main business lines demonstrates the positive reception of its technologies in the marketplace. Generated from the website

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company based in Oakville, Ontario, dedicated to serving patients by developing, manufacturing, and marketing high-quality branded and generic prescription pharmaceutical products. The company focuses on addressing the needs of patients through its innovative offerings and commitment to quality. Recently, ANI Pharmaceuticals has been active in the financial sector, reporting record first-quarter results for 2025 and participating in industry conferences, highlighting its ongoing growth and strategic initiatives. With a robust pipeline of products, ANI Pharmaceuticals continues to enhance its position in the biopharmaceutical landscape. Generated from the website